{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:39:18Z","timestamp":1776955158564,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bone.2025.117440","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:44:20Z","timestamp":1740829460000},"page":"117440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["RANKL-derived peptide MHP1-AcN attenuates ovariectomy-induced osteoporosis by targeting RANK and TNFR1 in mice"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3892-123X","authenticated-orcid":false,"given":"Takuya","family":"Kurihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-0787","authenticated-orcid":false,"given":"Munehisa","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-5969","authenticated-orcid":false,"given":"Yuki","family":"Etani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-6780","authenticated-orcid":false,"given":"Takaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-0999","authenticated-orcid":false,"given":"Yuji","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-539X","authenticated-orcid":false,"given":"Nagahiro","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-668X","authenticated-orcid":false,"given":"Atsushi","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-9864","authenticated-orcid":false,"given":"Taihei","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-7851","authenticated-orcid":false,"given":"Makoto","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-2562","authenticated-orcid":false,"given":"Atsushi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-7104","authenticated-orcid":false,"given":"Nan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3735-260X","authenticated-orcid":false,"given":"Satoshi","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-7277","authenticated-orcid":false,"given":"Takashi","family":"Kanamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-4229","authenticated-orcid":false,"given":"Ken","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-8209","authenticated-orcid":false,"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-1024","authenticated-orcid":false,"given":"Kosuke","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.bone.2025.117440_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bone.2025.117440_bb0010","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2012.06.100","article-title":"TNF-\u03b1 mediates the stimulation of sclerostin expression in an estrogen-deficient condition","volume":"424","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2025.117440_bb0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bone.2016.10.009","article-title":"Transcriptional control of Sost in bone","volume":"96","author":"Sebastian","year":"2017","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2025.117440_bb0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M22-1034","article-title":"Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.bone.2025.117440_bb0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2025.117440_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajco.12517","article-title":"Denosumab: prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures","volume":"13","author":"Pittman","year":"2017","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.bone.2025.117440_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bone.2025.117440_bb0045","article-title":"Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis","author":"Ebina","year":"2024","journal-title":"J. Bone Miner. Metab."},{"issue":"8","key":"10.1016\/j.bone.2025.117440_bb0050","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2174\/0929867327666200330142432","article-title":"Osteoporosis: mechanism, molecular target and current status on drug development","volume":"28","author":"Li","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bone.2025.117440_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7740079","article-title":"RANKL impairs the TLR4 pathway by increasing TRAF6 and RANK interaction in macrophages","volume":"2022","author":"Mota","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"22","key":"10.1016\/j.bone.2025.117440_bb0060","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1073\/pnas.1400544111","article-title":"OPG\/RANKL\/RANK axis is a critical inflammatory signaling system in ischemic brain in mice","volume":"111","author":"Shimamura","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bone.2025.117440_bb0065","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.4049\/jimmunol.177.6.3799","article-title":"Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice","volume":"177","author":"Maruyama","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35898-z","article-title":"Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke","volume":"8","author":"Shimamura","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51681-0","article-title":"Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis","volume":"9","author":"Ju","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bone.2025.117440_bb0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/immunohorizons.2000112","article-title":"Prevention of acute lung injury by a novel CD14-inhibitory receptor activator of the NF-kappaB ligand peptide in mice","volume":"5","author":"Ju","year":"2021","journal-title":"Immunohorizons"},{"issue":"9","key":"10.1016\/j.bone.2025.117440_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tibs.2012.06.002","article-title":"An improved understanding of TNFL\/TNFR interactions using structure-based classifications","volume":"37","author":"Magis","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.bone.2025.117440_bb0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00198-016-3830-1","article-title":"Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation","volume":"28","author":"Noguchi","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2025.117440_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116095","article-title":"Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation","volume":"152","author":"Tsukazaki","year":"2021","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2025.117440_bb0100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jbmr.2228","article-title":"Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-\u03b1 antibodies","volume":"29","author":"Tyagi","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117440_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-0716-1028-2_15","article-title":"Preparation of thin frozen sections from nonfixed and undecalcified hard tissues using Kawamoto\u2019s film method (2020)","volume":"2230","author":"Kawamoto","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bone.2025.117440_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117026","article-title":"Iguratimod suppresses sclerostin and receptor activator of NF-\u03baB ligand production via the extracellular signal-regulated kinase\/early growth response protein 1\/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice","volume":"181","author":"Miura","year":"2024","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.bone.2025.117440_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171962","article-title":"Anti-NF-\u03baB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice","volume":"8","author":"Takami","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2025.117440_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115525","article-title":"Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis","volume":"139","author":"Etani","year":"2020","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2025.117440_bb0130","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jbmr.2837","article-title":"Mechanical vibration mitigates the decrease of bone quantity and bone quality of leptin receptor-deficient Db\/Db mice by promoting bone formation and inhibiting bone resorption","volume":"31","author":"Jing","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117440_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/srep38062","article-title":"A novel therapeutic peptide as a partial agonist of RANKL in ischemic stroke","volume":"6","author":"Kurinami","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16843-7","article-title":"Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice","volume":"12","author":"Ju","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bone.2025.117440_bb0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00774-021-01206-5","article-title":"Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro","volume":"39","author":"Miyama","year":"2021","journal-title":"J. Bone Miner. Metab."},{"issue":"7","key":"10.1016\/j.bone.2025.117440_bb0150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI13890","article-title":"Crystal structure of the TRANCE\/RANKL cytokine reveals determinants of receptor-ligand specificity","volume":"108","author":"Lam","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bone.2025.117440_bb0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.14348\/molcells.2016.2286","article-title":"Design of a RANK-mimetic peptide inhibitor of osteoclastogenesis with enhanced RANKL-binding affinity","volume":"39","author":"Hur","year":"2016","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bone.2025.117440_bb0160","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/s41467-022-33006-4","article-title":"Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bone.2025.117440_bb0165","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1021\/acs.jmedchem.8b02027","article-title":"Development of small-molecules targeting receptor activator of nuclear factor-\u03baB ligand (RANKL)-receptor activator of nuclear factor-\u03baB (RANK) protein-protein interaction by structure-based virtual screening and hit optimization","volume":"62","author":"Jiang","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bone.2025.117440_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"18","key":"10.1016\/j.bone.2025.117440_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167790","article-title":"Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation","volume":"8","author":"Fu","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bone.2025.117440_bb0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jbmr\/zjae023","article-title":"Temporal patterns of osteoclast formation and activity following withdrawal of RANKL inhibition","volume":"39","author":"Kim","year":"2024","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2025.117440_bb0185","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1359\/jbmr.060604","article-title":"RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone","volume":"21","author":"Atkins","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2025.117440_bb0190","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jbmr.2170","article-title":"Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation","volume":"29","author":"T\u00e9letch\u00e9a","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2025.117440_bb0195","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.165.5.2719","article-title":"TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1\/2 pathway","volume":"165","author":"Chen","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bone.2025.117440_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030495","article-title":"TNF\u03b1 increases RANKL expression via PGE\u2082-induced activation of NFATc1","volume":"18","author":"Park","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.bone.2025.117440_bb0205","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.0504301102","article-title":"Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107","volume":"102","author":"Murali","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bone.2025.117440_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308132121","article-title":"Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex","volume":"121","author":"Zeng","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"592","key":"10.1016\/j.bone.2025.117440_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav5637","article-title":"Noncompetitive inhibitors of TNFR1 probe conformational activation states","volume":"12","author":"Lo","year":"2019","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.bone.2025.117440_bb0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jbmr.4781","article-title":"Suppression of remodeling and bone fragility","volume":"38","author":"Hernandez","year":"2023","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2025.117440_bb0225","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2011.04.001","article-title":"Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys","volume":"49","author":"Ominsky","year":"2011","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:47:21Z","timestamp":1762660041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":45,"alternative-id":["S8756328225000523"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117440","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RANKL-derived peptide MHP1-AcN attenuates ovariectomy-induced osteoporosis by targeting RANK and TNFR1 in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117440"}}